Company Shire PLC has received a new offer to buy shares of the company from AbbVie Inc. Shire PLC specializes in manufacturing of drugs to treat attention deficit and rare diseases. Final bid was 4% better than the previous. So that for one company's stock offer 53.20 British pounds.
Under the agreed terms of deal shareholders will receive 24.44 pounds per share plus 0.8960 shares AbbVie Inc. And will own 25% of the combined group. Merging capital leads to positive effects and will probably positively influence the quotes of AbbVie Inc. in the medium term. Until the end of the, quotations may grow by 8-9%.